Reid Laurenceinsider trades

In SEC Form 4 filings, Reid Laurence is listed as Director of Metagenomi Therapeutics, Inc. (MGX). In the last 90 days, Reid Laurence bought $23.4K of Metagenomi Therapeutics, Inc. (MGX) on the open market and sold none. The largest purchase was $23.3K of Metagenomi Therapeutics, Inc. (MGX) on Sep 9.

Companies and roles

Company	Role	Transactions	Last filed
MGXMetagenomi Therapeutics, Inc.	Director	2	Sep 11

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-11

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
MGXMetagenomi Therapeutics, Inc.	Sep 9	Sep 11	P	19,883	$1.17	Purchase +$23,263	19,883	No	Form 4
MGXMetagenomi Therapeutics, Inc.	Sep 9	Sep 11	P	117	$1.18	Purchase +$138	20,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.